Functional Recovery after Intramyocardial Injection of Adipose-Derived Stromal Cells Assessed by Cardiac Magnetic Resonance Imaging

Table 2

Left ventricle functional assessment by cardiac magnetic resonance.

	Baseline ()	12 months follow-up ()
LVEF [%]			0.052
LVEDV [mL]	230.2 (179.4-379.9)	231.7 (181.9-408.5)	0.075
LVESV [mL]	149.5 (86.2-298.5)	119.7 (81.2-314.3)	0.650
Stroke volume [mL]			0.025
Cardiac output [L/min]			0.073
Myocardial mass [mg]			0.974
LVEDV index [mL/m^2]	117.7 (95.5-185.3)	120.0 (97.2-204.1)	0.152
LVESV index [mL/m^2]	68.9 (50.2-147.2)	61.6 (45.4-161.5)	0.753
Stroke volume index [mL/m^2]			0.019
Cardiac index [L/min/m^2]			0.075
Myocardial mass index [mg/m^2]		98.1 ± 23.1	0.956
Body surface area [m^2]	1.94 ± 0.22	1.95 ± 0.22	0.782
Peak ejection rate index [mL/s/m^2]		220.0 ± 28.1	0.483
Peak filling rate index [mL/s/m^2]		185.5 ± 59.2	0.573
PER/LVEDV			0.673
PFR/LVEDV			0.790

All data presented as unless specified otherwise. Data presented as median with percentile: 25 and 75 LVEF: left ventricle ejection fraction; LVEDV: left ventricle end-diastolic volume; LVESV: left ventricle end-systolic volume; PER: peak ejection rate; PFR: peak filling rate.